Documentation Centre

 

 

  of 384 Next page

Go to page: of

Screenshot Date Categories Title Author Format
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399-1409 June 16, 2017 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399-1409 le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz RV, Wilding JP, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group Key Publications
Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet. 2017;389:1371-137 June 16, 2017 Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet. 2017;389:1371-137 Farr OM, Mantzoros CS Key Publications
Body-weight fluctuations and outcomes in coronary disease. N Engl J Med. 2017;376:1332-1340 June 14, 2017 Body-weight fluctuations and outcomes in coronary disease. N Engl J Med. 2017;376:1332-1340 Bangalore S, Fayyad R, Laskey R, DeMicco DA, Messerli FH, Waters DD Key Publications
Impact of weight loss-associated changes in detailed body composition as assessed by whole-body MRI on plasma insulin levels and homeostatis model assessment index. Eur J Clin Nutr. 2017;71:212-218 June 09, 2017 Impact of weight loss-associated changes in detailed body composition as assessed by whole-body MRI on plasma insulin levels and homeostatis model assessment index. Eur J Clin Nutr. 2017;71:212-218 Pourhassan M, Glüer CC, Pick P, Tigges W, Müller MJ Key Publications
Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients. Am J Clin Nutr. 2017;105:78-84 June 06, 2017 Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients. Am J Clin Nutr. 2017;105:78-84 Gallagher D, Kelley DE, Thornton J, Boxt L, Pi-Sunyer X, Lipkin E, Nyenwe E, Janumala I, Heshka S; MRI Ancillary Study Group of the Look AHEAD Research Group Key Publications
Substituting whole grains for refined grains in a 6-wk randomized trial favorably affects energy-balance metrics in healthy men and postmenopausal women. Am J Clin Nutr. 2017;105:589-599 June 02, 2017 Substituting whole grains for refined grains in a 6-wk randomized trial favorably affects energy-balance metrics in healthy men and postmenopausal women. Am J Clin Nutr. 2017;105:589-599 Karl JP, Meydani M, Barnett JB, Vanegas SM, Goldin B, Kane A, Rasmussen H, Saltzman E, Vangay P, Knights D, Chen CO, Das SK, Jonnalagadda SS, Meydani SN, Roberts SB Key Publications
Metabolomic profiles as reliable biomarkers of dietary composition.  Am J Clin Nutr. 2017;105:547-554 June 01, 2017 Metabolomic profiles as reliable biomarkers of dietary composition. Am J Clin Nutr. 2017;105:547-554 Esko T, Hirschhorn JN, Feldman HA, Hsu YH, Deik AA, Clish CB, Ebbeling CB, Ludwig DS Key Publications
5. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40:S44-S47 May 18, 2017 5. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40:S44-S47 American Diabetes Association Key Publications
Factors associated with adipocyte size reduction after weight loss interventions for overweight and obesity: a systematic review and meta-regression. Metabolism. 2017;67:31-40 May 11, 2017 Factors associated with adipocyte size reduction after weight loss interventions for overweight and obesity: a systematic review and meta-regression. Metabolism. 2017;67:31-40 Murphy J, Moullec G, Santosa S Key Publications
Mobile applications for obesity and weight management: current market characteristics. Int J Obes (Lond). 2017;41:200-202 May 04, 2017 Mobile applications for obesity and weight management: current market characteristics. Int J Obes (Lond). 2017;41:200-202 Nikolaou CK, Lean ME. Key Publications

  of 384 Next page

Go to page: of